["Taurolin-Gel" and Taurolin-Trockengel" in treatment of osseous tissue inflammation].
The activity and principles of administration of Taurolin have been presented. That drug was used in 15 patients with chronic osteitis. Healing by first intention was obtained in 10 patients, necrosis of the skin occurred in 3 patients, recurrence of inflammation was found in one patient in whom accessory sequestroctomy was performed in the last case of osteitis and arteriosclerosis healing was obtained by second intention. The clinical observation of 15 patients has revealed: a) irritating influence of Taurolin on the soft tissue, b) increased phase of secretion of exudate since the 5 day after surgery, c) bactericidal influence of the drug. Sterilization of the focus occurred at 2 to 3 weeks after surgery. The use of Taurolin requires experience, complete abiding by the principles of use of this drug and equipment with a set of Charrier's drains. The authors are carrying on further observation of the use of Taurolin in the treatment of osteitis.
Zawadziński
S
S
Kliniki Ortopedycznej AM w Warszawie.
Benke
G
G
Eluszkiewicz
S
S
Wasikowski
A
A
Zarek
S
S
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002908:Chronic Disease; D005782:Gels; D006801:Humans; D010000:Osteitis / Q000188:drug therapy*; D012008:Recurrence; D013654:Taurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013829:Thiadiazines / Q000627:therapeutic use*; D016896:Treatment Outcome
D000891:Anti-Infective Agents, Local; D005782:Gels; D013829:Thiadiazines; D013654:Taurine; C012566:taurolidine
"Taurolin--Gel" i "Taurolin--Trockengel" w leczeniu zapalenia tkanki kostnej. Doniesienie wstepne.